| Product Code: ETC7765098 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Neurodegenerative Drugs Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Neurodegenerative Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Neurodegenerative Drugs Market - Industry Life Cycle |
3.4 Jordan Neurodegenerative Drugs Market - Porter's Five Forces |
3.5 Jordan Neurodegenerative Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Jordan Neurodegenerative Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Jordan Neurodegenerative Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Neurodegenerative Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in Jordan |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in drug development for neurodegenerative disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in Jordan |
4.3.2 Limited healthcare infrastructure and resources for diagnosis and treatment of neurodegenerative diseases |
5 Jordan Neurodegenerative Drugs Market Trends |
6 Jordan Neurodegenerative Drugs Market, By Types |
6.1 Jordan Neurodegenerative Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Dopamine agonist, 2021- 2031F |
6.1.4 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Decarboxylase inhibitors, 2021- 2031F |
6.1.5 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Cholinesterase Inhibitors, 2021- 2031F |
6.1.6 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Immunomodulators, 2021- 2031F |
6.1.7 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Neurodegenerative Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.2.3 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.2.4 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.5 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Neurodegenerative Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Online Providers, 2021- 2031F |
6.3.4 Jordan Neurodegenerative Drugs Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
7 Jordan Neurodegenerative Drugs Market Import-Export Trade Statistics |
7.1 Jordan Neurodegenerative Drugs Market Export to Major Countries |
7.2 Jordan Neurodegenerative Drugs Market Imports from Major Countries |
8 Jordan Neurodegenerative Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted for neurodegenerative drugs in Jordan |
8.2 Adoption rate of new neurodegenerative drugs in the market |
8.3 Investment in research and development for neurodegenerative drugs in Jordan |
9 Jordan Neurodegenerative Drugs Market - Opportunity Assessment |
9.1 Jordan Neurodegenerative Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Jordan Neurodegenerative Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Jordan Neurodegenerative Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Neurodegenerative Drugs Market - Competitive Landscape |
10.1 Jordan Neurodegenerative Drugs Market Revenue Share, By Companies, 2024 |
10.2 Jordan Neurodegenerative Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here